Disclosure Of Fair Value Measurement [Text Block]

ROQUEFORT THERAPEUTICS PLC - Filing #5968009

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
5,750,745 GBP
6,088,568 GBP
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
861,726 GBP
589,025 GBP
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
5,265,071 GBP
4,619,793 GBP
1,357,366 GBP
69,931 GBP
3,700,000 GBP
407,000 GBP
4,889,019 GBP
5,499,543 GBP
4,293,268 GBP
4,403,094 GBP
1,291,500 GBP
12,680 GBP
3,700,000 GBP
385,537 GBP
7,206,636 GBP
4,403,094 GBP
375,135 GBP
2,548,728 GBP
1,291,500 GBP
14,365 GBP
3,700,000 GBP
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.